What does a progesterone level of 7.3 ng/mL indicate about the phase of a woman's menstrual cycle and potential pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Progesterone Level Interpretation: 7.3 ng/mL

A progesterone level of 7.3 ng/mL most likely indicates the early luteal phase of the menstrual cycle, suggesting recent ovulation has occurred but the corpus luteum has not yet reached peak progesterone production. This level is too low to confirm pregnancy but too high for the follicular or ovulation phases.

Clinical Interpretation by Menstrual Cycle Phase

What This Level Rules Out

  • Not follicular phase: The level of 7.3 ng/mL far exceeds the follicular phase range of 0.1-0.9 ng/mL, definitively excluding this phase 1.

  • Not ovulation phase: While 7.3 ng/mL falls within the broad ovulation phase range of 0.1-12.0 ng/mL, progesterone begins rising only after ovulation occurs, making this more consistent with early luteal phase 1.

  • Not postmenopausal: The level is dramatically elevated compared to the postmenopausal range of 0.0-0.1 ng/mL 1.

What This Level Suggests

  • Early-to-mid luteal phase (most likely): The level of 7.3 ng/mL falls within the luteal phase range of 1.8-23.9 ng/mL, but is on the lower end of this spectrum 1. In normal pregnancies, median progesterone levels range from 57.5 nmol/L (approximately 18 ng/mL) to 80.8 nmol/L (approximately 25 ng/mL) from 5-13 weeks gestation 1.

  • Adequate for confirming ovulation: A progesterone level above 3-4 ng/mL generally confirms ovulation has occurred, and 7.3 ng/mL meets this threshold 2.

Pregnancy Considerations

  • Unlikely to represent viable early pregnancy: The level of 7.3 ng/mL is substantially below the first trimester range of 11.0-44.3 ng/mL 1. In women with threatened miscarriage who subsequently had spontaneous miscarriage, progesterone levels ranged from only 19.0-30.3 nmol/L (approximately 6-9.5 ng/mL), which overlaps with this patient's level 1.

  • May indicate threatened miscarriage if pregnancy suspected: In the threatened miscarriage cohort, median progesterone levels were uniformly lower by approximately 10 nmol/L (3 ng/mL) at every gestational week compared to normal pregnancies 1. A level of 7.3 ng/mL would be concerning for pregnancy viability if pregnancy is suspected clinically.

Clinical Action Based on Context

If Timing Ovulation or Assessing Luteal Function

  • Repeat measurement in 5-7 days: Peak luteal progesterone typically occurs 7-8 days after ovulation. If this represents early luteal phase, a repeat level should show significant increase to 15-25 ng/mL in a normal cycle 3, 1.

  • Consider luteal phase deficiency if repeat level remains low: Progesterone levels that fail to rise above 10 ng/mL in the mid-luteal phase are associated with reduced fertility outcomes 2.

If Pregnancy is Suspected

  • Obtain quantitative β-hCG immediately: This is the definitive test to confirm or exclude pregnancy 4. The progesterone level alone cannot reliably distinguish early luteal phase from very early or failing pregnancy.

  • If β-hCG confirms pregnancy and progesterone remains 7.3 ng/mL: This represents a concerning finding. Normal early pregnancy should show progesterone levels >11 ng/mL by the time β-hCG is detectable 1. Consider transvaginal ultrasound to assess viability and location.

Common Pitfalls to Avoid

  • Do not use progesterone alone to diagnose pregnancy: While low progesterone is associated with pregnancy complications, the level of 7.3 ng/mL overlaps between late luteal phase and very early/failing pregnancy. Always correlate with β-hCG and clinical context 4, 1.

  • Do not assume adequate luteal function from a single measurement: One progesterone level of 7.3 ng/mL does not confirm adequate luteal phase support. Peak mid-luteal levels (typically day 21 of a 28-day cycle) should be measured for proper assessment 2, 1.

  • Do not start progesterone supplementation based solely on this level without clear indication: Progesterone supplementation in pregnancy is indicated for specific high-risk scenarios (prior preterm birth, short cervix), not for isolated low progesterone levels in early pregnancy without other risk factors 4, 5, 6.

References

Research

Midluteal Progesterone: A Marker of Treatment Outcomes in Couples With Unexplained Infertility.

The Journal of clinical endocrinology and metabolism, 2018

Research

Effectiveness of vaginal administration of progesterone.

British journal of obstetrics and gynaecology, 1985

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Progesterone Regimens for Early Pregnancy Bleeding and Recurrent Miscarriage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Prevention of Preterm Birth with Progesterone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.